Skip to main content
. 2008 Mar;2(1):159–166.

Table 1.

Patient characteristics and results of combined photodynamic therapy and intravitreal bevacizumab

Pre-treat. V/A
6-Mo. V/A
Patient Sex Age (y) CNV size (μm) CNV type CNV location No. of retreatment dicimal Ft. 20/ LogMAR dicimal Ft. 20/ LogMAR CRT basic (μm) CRT final (μm)
1 F 70 1,600 PC SF 1 0.1 200 1 0.2 100 0.7 520 280
2 F 65 2,000 PC SF 1 0.2 100 0.7 0.32 60 0.5 550 275
3 M 72 2,200 O SF 1 0.12 160 0.9 0.25 80 0.6 650 240
4 M 80 2,300 PC JF 2 0.05 400 1.3 0.05 400 1.3 850 400
5 M 65 1,800 O JF 1 0.1 200 1 0.12 160 0.9 800 270
6 M 62 1,600 PC SF 1 0.1 200 1 0.1 200 1 800 310
7 F 72 1,400 O SF 1 0.2 100 0.7 0.32 60 0.5 620 230
8 F 73 2,000 O JF 1 0.2 100 0.7 0.25 80 0.6 450 250
9 M 75 950 PC JF 1 0.05 400 1.3 0.5 40 0.3 800 280
10 M 80 850 PC JF 1 0.25 80 0.6 0.32 60 0.5 450 280
11 M 77 2,000 PC SF 1 0.1 200 1 0.2 100 0.7 420 250
12 F 80 2,400 O SF 1 0.1 200 1 0.25 80 0.6 500 230
13 M 70 2,400 PC SF 1 0.1 200 1 0.2 100 0.7 520 220
14 M 69 3,000 O SF 2 0.05 400 1.3 0.1 200 1 400 210
15 M 62 2,800 O SF 2 0.05 400 1.3 0.05 400 1.3 715 320
16 F 80 2,700 PC JF 1 0.12 160 0.9 0.2 100 0.7 400 270
17 F 82 2,600 PC SF 1 0.05 400 1.3 0.1 200 1 580 280
18 M 77 2,000 O JF 1 0.2 100 0.7 0.25 80 0.6 600 220
Mean 72.8 2,033 1.1667 0.11 20/190 0.98 0.18 20/112 0.75 590.278 267.5
SD 6.5 597.29 0.3835 2.4 lines 0.24 2.8 lines 0.277 149.5 45.25

Abbreviations: CRT, central retinal thickness; SD, standard deviation; Ft., feet; CNV, subretinal neovascular membrane; V/A, best corrected visual acuity.